# GENOPLAN INC. — Form D

GENOPLAN INC. of NEW YORK, NY, a company, filed a Form D exempt-offering notice with the SEC on 2016-03-21. The offering totals $5.0M, of which $4.2M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2016-03-21
- Form: D
- Accession: 0001015325-16-000043
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $5.0M
- Amount sold: $4.2M
- Remaining: $800K
- Investors: 4
- Date of first sale: 2016-03-14
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-259639

## Issuer

- Name: GENOPLAN INC.
- CIK: 0001669736
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2015
- Address: C/O WEWORK, NEW YORK, NY, 10018
- Phone: (317) 829-4522

## Officers, directors & promoters (3)

| Name | Role | Location |
| --- | --- | --- |
| Byungkyu Kang | Director | New York, NY |
| Byungkyu Kang | Executive Officer | New York, NY |
| Byungkyu Kang | Promoter | New York, NY |

## More

- [CIK 1669736 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1669736&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001015325-16-000043.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.